What's the Difference Between GLOW and KLOW?
KLOW is GLOW with one peptide added. The three peptides GLOW is built on (GHK-Cu, BPC-157, and full-length TB-4) sit in KLOW at the exact same amounts. KLOW layers 10 mg of KPV on top, and that added 10 mg is the entire 70 mg → 80 mg difference.
| Peptide | In GLOW | In KLOW | What it does |
|---|---|---|---|
| GHK-Cu | 50 mg | 50 mg | Rebuilds collagen |
| BPC-157 | 10 mg | 10 mg | Restores blood supply to the repair area |
| TB-4 | 10 mg | 10 mg | Organizes repair cells, limits scarring |
| KPV | — | 10 mg | Blocks the inflammation switch (NF-κB¹) |
| Total | 70 mg | 80 mg |
This is why dosing comes out the same even though the vials are different sizes. Each dose is built around GHK-Cu, at 2 mg per injection, and GHK-Cu is the same 50 mg in both vials, so one vial runs about 25 doses either way. It is not 70 mg ÷ 2 mg = 35 doses; you dose against the GHK-Cu alone, not the vial's total mass. KLOW's extra 10 mg only adds KPV to every shot; it does not change what you draw or how long a vial lasts.
KPV is what makes KLOW its own tool. It stops inflammatory genes from switching on in the first place, a different route than NSAIDs, which act after inflammation has already started. It earns its place only when inflammation is active, clearing the interference so the collagen work can land. Mechanism depth for all four peptides is on the GHK-Cu, BPC-157, TB-500 / TB-4, and KPV guides.
Should You Use GLOW or KLOW?
Use GLOW if your skin is calm and the goal is firmness, fine lines, or texture. Use KLOW if inflammation is in the picture — rosacea, post-procedure redness, reactive flushing, or inflammatory acne. Same base, same dosing math.
| Your skin / goal | Pick |
|---|---|
| Aging, fine lines, firmness loss, texture, hair-growth support | GLOW |
| Calm baseline, no active redness | GLOW |
| Rosacea or chronic facial redness | KLOW |
| Post-laser or post-microneedling recovery | KLOW |
| Inflammatory acne or reactive, flushing-prone skin | KLOW |
If you are not sure, start with GLOW. Switch to KLOW if redness or reactivity limits your results — the dose math does not change, so it costs you nothing to move. The per-dose details live on the GLOW calculator and the KLOW calculator.
Is KLOW Good for Rosacea?
KLOW is the rosacea pick in this pair. The inflammation switch (NF-κB) drives the flushing and reactive flares that define rosacea, and KPV pre-empts that activation rather than blocking it after it fires. Most users see baseline redness drop in the first one to two weeks, before the collagen work surfaces at weeks 4–8.
GLOW does not address this. Without KPV it carries no direct brake on inflammatory tone, so collagen and vascular signals land on tissue that is still fighting them.
One caveat: if redness persists past week 6 on KLOW, the driver is more likely mast-cell-mediated than NF-κB-mediated. Raising the KLOW dose will not reach it, and mast-cell-targeted treatment is the better next step.
Can You Switch Between GLOW and KLOW?
Yes, mid-cycle, with no change to the math. The three shared peptides sit at identical masses, so moving from GLOW to KLOW only adds KPV to each dose, and moving back drops it. Some users run KLOW during active flares (rosacea, post-procedure weeks, reactive stretches) and GLOW the rest of the time. Reconstitution and draw volumes are the same either way, covered on the GLOW and KLOW calculators.
Can You Use GLOW or KLOW for Injuries?
Neither one is a real injury protocol on its own. The mix is tuned for skin, so it underdoses TB-4 (the repair-cell peptide) for serious tissue healing, and it has no NAD+, the cellular fuel that heavy repair burns through. KLOW gets closer, because its KPV calms the inflammation that stalls healing — but it still needs a separate, larger shot of full-length TB-4 to reach the dose an injury needs. The KLOW calculator covers the injury dosing, and the Wolverine Stack is the protocol built for soft-tissue repair.
GLOW vs. KLOW: Cost and Composition
The only composition difference is KLOW's extra 10 mg of KPV (the full breakdown is in the table up top). That 10 mg is what turns a plain skin blend into one that also controls inflammation. On price, the source matters far more than those 10 mg, so KLOW runs only a little above GLOW. Both go through a standard 12-week cycle on two to three vials, depending on how often you inject.
How to Dose GLOW and KLOW
Dosing is identical for both. Inject once a day to start, then taper to a few times a week as the cycle goes on, with each dose set to 2 mg of GHK-Cu. That one number is all you set; the GLOW calculator and KLOW calculator turn it into how much bacteriostatic water to add and how many units to draw for your vial size.
What the Evidence Says About GLOW and KLOW
No trial has tested either blend as a formulation. The evidence is per-component:
| Peptide | Evidence base |
|---|---|
| GHK-Cu | Split-face human dermatology trials on wrinkle depth and skin density; broad microarray gene-expression mapping; decades of cosmetic and wound-healing literature. |
| BPC-157 | 100+ preclinical studies in injury, GI, and tendon models; small early human trials (2024–2025) on tendon and gut. |
| TB-4 | Preclinical wound-healing data; Phase 2/3 ophthalmic trials in corneal healing; cosmetic dosing extrapolated from injury models. |
| KPV | NF-κB mechanism data; small clinical trials in IBD (oral) and atopic dermatitis (topical/oral). No published subcutaneous human data for systemic effects. |
Synergy across the blend is inferred from the individual mechanisms, not measured in combination. Neither blend is FDA-approved, and the components are largely unpatentable, which removes the commercial incentive to fund a combination trial.
FAQ
What is the difference between GLOW and KLOW?
KLOW is GLOW plus KPV. The shared three peptides (GHK-Cu, BPC-157, full-length TB-4) are identical in both; KPV blocks the inflammation switch (NF-κB). Use GLOW for calm skin, KLOW when inflammation is part of the picture.
Which is better for me, GLOW or KLOW?
Calm skin with a firmness or fine-line goal: GLOW. Rosacea, post-procedure redness, inflammatory acne, or reactive skin: KLOW. Start with GLOW and switch if inflammation limits results.
Is KLOW good for rosacea?
Yes, it is the rosacea pick here. KPV pre-empts the NF-κB-driven flushing that defines rosacea, and most users see redness drop in one to two weeks. If it persists past week 6, the driver is more likely mast-cell-mediated.
Can I switch between GLOW and KLOW mid-cycle?
Yes. The shared peptides are at identical masses, so the dose math does not change. Switching only adds or drops KPV.
Does KLOW cost more than GLOW?
Slightly, for the extra 10 mg of KPV, but per-vial price depends more on the source. Both run the same 12-week cycle.
Can I use GLOW or KLOW for injury?
Not on their own. Both underdose TB-4 for serious repair and have no NAD+. See the injury dosing on the KLOW calculator or the Wolverine Stack.
Can I make GLOW or KLOW from separate vials?
Yes, but it means three or four cold-chain items, more sterile draws per dose, and matching the ratio yourself. A pre-mixed vial trades cost for fewer mistakes.
Related Topics
- GLOW Dosage Calculator & Protocol — the three-peptide base, full dosing
- KLOW Dosage Calculator & Protocol — adds KPV; covers the injury dosing too
- GHK-Cu for Skin — the collagen peptide both blends share
- KPV Guide — the inflammation-control peptide that defines KLOW
- BPC-157 Guide — tissue repair and capillary supply
- Wolverine Stack — BPC-157 + TB-500 for structural injury
References
¹ KPV anti-inflammatory mechanism — NF-κB nuclear-import blockade, cytokine suppression, M1-to-M2 immune-cell shift; mechanism distinct from the alpha-MSH parent: Luger TA, Brzoska T. Ann Rheum Dis 2007. PubMed 17921186
Medical Disclaimer
The content in this protocol guide is for informational purposes only and does not constitute medical advice. Always consult with a qualified healthcare provider before beginning any new protocol, supplement, or medication.